Vielight Inc is poised at the forefront of brain photobiomodulation technology. We combine science with engineering ingenuity to develop devices that incorporate novel methods of delivering photons to the brain and inner systems. Our mission is to engineer photobiomodulation devices that are safe and effective, easy to use and affordable – all to truly help improve one’s quality of life.
The Vielight story started in 1995, when Lew Lim and his colleagues at Silicon Valley invented intranasal photobiomodulation as a non-invasive method of introducing therapeutic photonic energy into the human body. The research and development continued throughout the next decade before Vielight Inc was founded to commercialize the invention.
Officially incorporated in Canada in 2011, Vielight Inc has since evolved into a formidable team of engineers, scientists and business professionals dedicated towards taking the technology to as many people as possible. Vielight’s footprint currently covers North America, Europe, Australia and many other markets.
Throughout the years, several research institutions have adopted the use of Vielight technology in clinical trials, namely, Boston University School of Medicine and the United States Department of Veterans Affairs.
At the end of 2015, results from the initial pilot study conducted in collaboration with Harvard Medical School and Boston University School of Medicine were deemed good enough to warrant further investment and grants for bigger upcoming clinical trials approved by the FDA and Health Canada. (find out more here)
Today, we strive to look for new opportunities and expand our range of solutions by working in collaboration with some world-renowned research institutions in the field of photobiomodulation. Our goal is to combine that pioneering spirit with a passionate commitment towards improving people’s lives.
Lew Lim, PhD, DNM, MBA, FCMA, Grad.Cert.Eng.
Founder & CEO
VP, Business Development
Hilary Au, PhD, MSc, BSc Biochem.
VP, Science, Materials & Logistics
Glynn Jones, CPA, CA, B Com.
Chief Financial Officer
Liyao Ji, MSc. Biochem.
Quality and Regulatory Affairs Manager
Edward D’Mello, MBA, BSc Comms.
Communications and Media Manager
Dominic Jake King Lim, BSc Comp Math.
Katherine Spencer, BSc Biopsych.
Customer Service and Administration
Research and Development division
Teng Howe, BSc Mech Eng.
Chief Engineer, Mechanical & Manufacturing
Kam Yip, MBA, BSc Elec Eng.
Electronics & Software Engineer
Janine Liburd, PhD, MSc Biochem.
Clinical Trial Manager and Research Scientist
Gena Loheswaran, PhD, MSc Pharmacology.
Mahta Karimpoor, PhD Medical Biophysics.
Research Scientist and Biomedical Engineer
Michael Hamblin, PhD, MSc, HBsc
Harvard Medical School
Email : email@example.com
346A Jarvis Street
+1-877-355-8012 (Toll-free for US and Canada)